Literature DB >> 2165396

Are there subtypes of the inositol 1,4,5-trisphosphate receptor?

M A Varney1, J Rivera, A Lopez Bernal, S P Watson.   

Abstract

We have compared the properties of the [3H]Ins(1,4,5)P3-binding sites from a number of tissues in an attempt to determine if heterogeneity exists within the Ins(1,4,5)P3-receptor family. The binding of Ins(1,4,5)P3 was characterized in detail by using membranes prepared from human uterine smooth muscle and bovine adrenal cortex. Ins(1,4,5)P3 exhibited an approx. 5 times greater affinity for the binding site in adrenal cortex (KD = 9.81 +/- 1.92 nM) compared with uterine smooth muscle (KD = 37.1 +/- 1.8 nM). The binding was dependent on pH in both tissues, with a maximum at pH 8.3; at this pH various inositol phosphates and nucleotides competed for the binding sites with similar potencies on both tissues. However, the binding of Ins(1,4,5)P3 to the uterine smooth-muscle membranes was Ca2(+)-sensitive, whereas that to the bovine adrenal cortex was not; furthermore, heparin displaced the binding of Ins(1,4,5)P3 in the uterus with an IC50 value (concn. of displacer giving 50% inhibition of specific binding) of 3.9 micrograms/ml (2.5, 6.4; lower, upper range), compared with a value of 22 (13, 30) micrograms/ml in adrenal cortex. In view of the ability of Ins(1,4,5)P3 and heparin to distinguish between these binding sites, their effect on other tissues was examined. Ins(1,4,5)P3 showed a similar affinity for receptors located in the bovine cerebellum to those in the bovine adrenal cortex, but heparin displaced Ins(1,4,5)P3 binding with a 5-fold greater affinity from the cerebellum. Ins(1,4,5)P3 had a 2-fold greater affinity for its receptor with human platelets, as compared with human uterus, but heparin was unable to distinguish between these sites. In guinea-pig ileum, Ins(1,4,5)P3 displayed a similar affinity for the receptors in the longitudinal muscle compared with the circular muscle, but heparin could distinguish between these sites. These data show that small differences exist between tissues, but no clear picture is apparent. It is possible that these results reflect tissue-dependent factors such as phosphorylation, the presence of calmedin etc., rather than the presence of receptor subtypes or species difference.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2165396      PMCID: PMC1131554          DOI: 10.1042/bj2690211

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  Effect of the lipid environment on the differential affinity of purified cerebral and atrial muscarinic acetylcholine receptors for pirenzepine.

Authors:  G Berstein; T Haga; A Ichiyama
Journal:  Mol Pharmacol       Date:  1989-10       Impact factor: 4.436

2.  Mass measurements of inositol(1,4,5)trisphosphate in rat cerebral cortex slices using a radioreceptor assay: effects of neurotransmitters and depolarization.

Authors:  R A Challiss; I H Batty; S R Nahorski
Journal:  Biochem Biophys Res Commun       Date:  1988-12-15       Impact factor: 3.575

Review 3.  Inositol phosphates: proliferation, metabolism and function.

Authors:  R F Irvine; R M Moor; W K Pollock; P M Smith; K A Wreggett
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1988-07-26       Impact factor: 6.237

4.  Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400.

Authors:  T Furuichi; S Yoshikawa; A Miyawaki; K Wada; N Maeda; K Mikoshiba
Journal:  Nature       Date:  1989-11-02       Impact factor: 49.962

5.  Purified inositol 1,4,5-trisphosphate receptor mediates calcium flux in reconstituted lipid vesicles.

Authors:  C D Ferris; R L Huganir; S Supattapone; S H Snyder
Journal:  Nature       Date:  1989-11-02       Impact factor: 49.962

Review 6.  Inositol polyphosphates and neuronal calcium homeostasis.

Authors:  S R Nahorski
Journal:  Trends Neurosci       Date:  1988-10       Impact factor: 13.837

7.  Heterogeneity of [3H]inositol 1,4,5-trisphosphate binding sites in adrenal-cortical membranes. Characterization and validation of a radioreceptor assay.

Authors:  R A Challiss; E R Chilvers; A L Willcocks; S R Nahorski
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

8.  Mass changes of inositol(1,4,5)trisphosphate in trachealis muscle following agonist stimulation.

Authors:  E R Chilvers; R A Challiss; P J Barnes; S R Nahorski
Journal:  Eur J Pharmacol       Date:  1989-05-30       Impact factor: 4.432

9.  Hormonal regulation of inositol 1,4,5-trisphosphate receptor in rat liver.

Authors:  J P Mauger; M Claret; F Pietri; M Hilly
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

10.  Development of a novel, Ins(1,4,5)P3-specific binding assay. Its use to determine the intracellular concentration of Ins(1,4,5)P3 in unstimulated and vasopressin-stimulated rat hepatocytes.

Authors:  S Palmer; K T Hughes; D Y Lee; M J Wakelam
Journal:  Cell Signal       Date:  1989       Impact factor: 4.315

View more
  13 in total

1.  Regulation of the cerebellar inositol 1,4,5-trisphosphate receptor by univalent cations.

Authors:  Jean-François Coquil; Samantha Blazquez; Sabrina Soave; Jean-Pierre Mauger
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

Review 2.  Inositol trisphosphate receptors in smooth muscle cells.

Authors:  Damodaran Narayanan; Adebowale Adebiyi; Jonathan H Jaggar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-23       Impact factor: 4.733

Review 3.  IP(3) receptors: toward understanding their activation.

Authors:  Colin W Taylor; Stephen C Tovey
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-10-27       Impact factor: 10.005

4.  The properties of a subtype of the inositol 1,4,5-trisphosphate receptor resulting from alternative splicing of the mRNA in the ligand-binding domain.

Authors:  J P Lièvremont; H Lancien; M Hilly; J P Mauger
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

5.  Selective recognition of inositol phosphates by subtypes of the inositol trisphosphate receptor.

Authors:  E P Nerou; A M Riley; B V Potter; C W Taylor
Journal:  Biochem J       Date:  2001-04-01       Impact factor: 3.857

6.  Comparative localization of inositol 1,4,5-trisphosphate and ryanodine receptors in intestinal smooth muscle: an analytical subfractionation study.

Authors:  M Wibo; T Godfraind
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

7.  Micromolar calcium decreases affinity of inositol trisphosphate receptor in vascular smooth muscle.

Authors:  D Benevolensky; I I Moraru; J Watras
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

8.  Inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate binding sites in smooth muscle.

Authors:  L Zhang; M E Bradley; M Khoyi; D P Westfall; I L Buxton
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

9.  Influence of Mg2+ and pH on n.m.r. spectra and radioligand binding of inositol 1,4,5-trisphosphate.

Authors:  A M White; M A Varney; S P Watson; S Rigby; C S Liu; J G Ward; C B Reese; H C Graham; R J Williams
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

10.  Pharmacological Characterization of Inositol 1,4,5-tris Phosphate Receptors in Human Platelet Membranes.

Authors:  Yogesh Dwivedi; Ghanshyam N Pandey
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.